Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

[1]  C. Aghajanian.  Treatment of low-risk gestational trophoblastic neoplasia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Berkowitz,et al.  Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. , 2010, The Journal of reproductive medicine.

[3]  W. Kang,et al.  Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia. , 2010, Gynecologic oncology.

[4]  V. Fülöp,et al.  30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. , 2010, The Journal of reproductive medicine.

[5]  M. Seckl,et al.  The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1 , 2010, British Journal of Cancer.

[6]  S. Wilailak,et al.  Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial , 2009, International Journal of Gynecologic Cancer.

[7]  R. Coleman,et al.  Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia. , 2009, Gynecologic oncology.

[8]  G. Chalouhi,et al.  Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity. , 2009, American journal of obstetrics and gynecology.

[9]  M. Seckl,et al.  Practical issues in the management of low-risk gestational trophoblast tumors. , 2008, The Journal of reproductive medicine.

[10]  N. Sebire,et al.  Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  A. Rademaker,et al.  Gestational Trophoblastic Neoplasia: Treatment Outcomes , 2008, Obstetrics and gynecology.

[12]  J. Benedet,et al.  Gestational trophoblastic neoplasia, FIGO 2000 staging and classification , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[13]  G. Rustin,et al.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Mclellan,et al.  Gestational trophoblastic disease. , 2001, Obstetrics and gynecology clinics of North America.

[15]  G. Rustin,et al.  Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. , 1998, European journal of cancer.

[16]  E S Newlands,et al.  EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Newlands,et al.  Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  H. Homesley.  Development of single-agent chemotherapy regimens for gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[19]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.